PhaseBio Pharmaceuticals Management
Management criteria checks 3/4
PhaseBio Pharmaceuticals' CEO is Jonathan Mow, appointed in Mar 2015, has a tenure of 7.92 years. total yearly compensation is $1.53M, comprised of 36.7% salary and 63.3% bonuses, including company stock and options. directly owns 0.37% of the company’s shares, worth €513.08. The average tenure of the management team and the board of directors is 3.3 years and 4.4 years respectively.
Key information
Jonathan Mow
Chief executive officer
US$1.5m
Total compensation
| CEO salary percentage | 36.7% |
| CEO tenure | 7.9yrs |
| CEO ownership | 0.4% |
| Management average tenure | 3.3yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$103m |
| Mar 31 2022 | n/a | n/a | -US$115m |
| Dec 31 2021 | US$2m | US$562k | -US$131m |
| Sep 30 2021 | n/a | n/a | -US$118m |
| Jun 30 2021 | n/a | n/a | -US$112m |
| Mar 31 2021 | n/a | n/a | -US$111m |
| Dec 31 2020 | US$2m | US$529k | -US$99m |
| Sep 30 2020 | n/a | n/a | -US$80m |
| Jun 30 2020 | n/a | n/a | -US$66m |
| Mar 31 2020 | n/a | n/a | -US$47m |
| Dec 31 2019 | US$1m | US$436k | -US$39m |
| Sep 30 2019 | n/a | n/a | -US$33m |
| Jun 30 2019 | n/a | n/a | -US$29m |
| Mar 31 2019 | n/a | n/a | -US$27m |
| Dec 31 2018 | US$596k | US$359k | -US$24m |
| Sep 30 2018 | n/a | n/a | -US$22m |
| Jun 30 2018 | n/a | n/a | -US$16m |
| Mar 31 2018 | n/a | n/a | -US$12m |
| Dec 31 2017 | US$436k | US$338k | -US$10m |
Compensation vs Market: Jonathan's total compensation ($USD1.53M) is above average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Jonathan's compensation has been consistent with company performance over the past year.
CEO
Jonathan Mow (57 yo)
7.9yrs
Tenure
US$1,529,108
Compensation
Mr. Jonathan P. Mow, MBA has been Chief Executive Officer of PhaseBio Pharmaceuticals, Inc. since March 2015 and serves as its President. Mr. Mow served as Chief Business Officer of PhaseBio Pharmaceutical...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.9yrs | US$1.53m | 0.37% $ 513.1 | |
| Chief Medical Officer | 6.8yrs | US$856.30k | 0% $ 0 | |
| Chief Restructuring Officer & Principal Financial Officer | less than a year | no data | no data | |
| Senior Vice President of Technical Operations | 1.3yrs | no data | 0.083% $ 115.2 | |
| SVP, General Counsel & Corporate Secretary | 3.3yrs | no data | 0.017% $ 23.6 | |
| Senior Vice President of Human Resources | 3.3yrs | no data | no data | |
| Global Head of Regulatory Affairs & Quality Assurance | no data | no data | no data | |
| Chief Commercial Officer | 1.3yrs | no data | 0.040% $ 55.9 |
3.3yrs
Average Tenure
53yo
Average Age
Experienced Management: 2K4's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.4yrs | US$1.53m | 0.37% $ 513.1 | |
| Independent Director | 4yrs | US$82.86k | 0% $ 0 | |
| Independent Director | 4.2yrs | US$76.36k | 0.012% $ 16.8 | |
| Independent Chairman of the Board | 21.1yrs | US$116.36k | 0.066% $ 92.0 | |
| Independent Director | 1.4yrs | US$62.58k | 0% $ 0 | |
| Independent Director | 4.6yrs | US$85.36k | 0% $ 0 | |
| Independent Director | 4.9yrs | US$87.36k | 0.076% $ 105.5 | |
| Independent Director | 3yrs | US$77.86k | 0% $ 0 |
4.4yrs
Average Tenure
56yo
Average Age
Experienced Board: 2K4's board of directors are considered experienced (4.4 years average tenure).